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INTRODUCTION 
 
 Iron deficiency is the commonest cause of anemia not only in 
developing countries but also in developed world. Even in U.S.A, about 20% 
cases of anemia is attributed iron deficiency. In countries like India, the 
prevalence is even higher. Patients with cyanotic heart disease in whom the 
picture of erythrocytosis predominates are no exception. The red cell 
production depends on the availability of nutrients, including iron, vitamin B-
12, folic acid and pyriodoxine. Iron plays a central role along with 
erythropoietin and committed stem cells in determining red cell production.  
 
 Anemia poses a special problem in patients with cyanotic congenital 
heart disease. It is an important risk factor for the cyanotic spells and 
cerebrovascular accident. It increase blood viscosity by its effect on the 
physical properties of red cells, relatively at a lower hematocrit level. At the 
same time the correction of anemia without monitoring the hematological 
parameters, may also cause an undue rise in hematocrit, worsening the 
situation.  
 
 To complicate issues further, the diagnosis of iron deficiency anemia is 
not possible clinically due to the association of erythrocytosis. The detection 
of anemia by hemoglobin or by hematocrit is also not accurate as both those 
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parameters will be elevated and hence the definition of anemia, as applicable 
to the general population can not be applied to those patients. Moreover, the 
iron deficiency anemia in patients with cyanotic congenital heart disease is 
more often a relative anemia. The term ‘relative iron deficiency anemia’ 
designates, an iron supply that would be adequate to meet the needs of basal 
erythropoiesis but which is not adequate to meet the needs of an expanded 
erythroid marrow. This leads to the nutritional deficiency.  
 
 Controversies exist in the diagnosis of iron deficiency in patients with 
cyanotic congenital heart disease. Automated equipments have increased the 
dependability of mean corpuscular volume, but with some limitations. Change 
take time to develop due to slow turnover of circulatory red cells, so that it 
will be possible to detect abnormalities only after the condition has been 
present for months.  
 
 Iron deficiency in a patient with cyanotic, heart disease plays a pivotal 
role since when it is uncorrected, it increases the risk of complications and 
when over enthusiastically corrected, it once again aggravates the 
complications. Now a days, the conservative approach is followed towards 
phlebotomy since it increases the risk of iron deficiency.  
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 This study was conducted in order to estimate the incidence of iron 
deficiency in cyanotic heart disease patients in our hospital and to find out the 
best modality to detect it early in a polycythemic patient.  
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AIMS AND OBJECTIVES   
 To assess Iron deficiency anemia in congenital cyanotic heart disease 
patients using serum ferritin levels as a sensitive index and to correlate 
other red cell indices with ferritin levels. 
 To compare the red cell indices of cyanotic heart disease patients with 
that of normal population. 
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MATERIALS 
 
SUBJECTS  
 All patients with established congenital cyanotic heart diseases 
attending Govt. Rajaji Hospital, Chennai between October 2004 – September 
2006 formed the study group. Control group was formed by age and sex 
matched patient’s attendants. 
  
PERIOD OF STUDY  
 Two years  
 October 2004 to September 2006 
 
ELIGIBILITY CRITERIA  
1. Patients with established cyanotic heart disease over 12 year of age.  
2. The disease must have been proved by all available modes of 
investigations.    
 
Patients with any significant degree of infection were excluded from 
the study since serum ferritin level tend to be altered by infection.  
 
Informed consent was obtained from patients and controls.  
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METHODOLOGY 
 
 Serum ferritin was assayed using pathozyme Ferritin Ref. OD 407 kit.  
 
 It is an enzyme immunoassay for the quantitative determination of 
ferritin in human serum. 
 
 Specific anti ferritin antibodies are coated on to microtitre wells. Test 
sera are applied. Then monoclonal anti-ferritin labeled with horse radish 
peroxidase enzyme is added. If human ferritin is present in the sample, it will 
combine with the antibody on the well and the enzyme conjugate resulting in 
ferritin molecule being sandwiched between the solid phase and enzyme 
linked antibodies. After incubation for about 45 minutes, the wells are washed 
with distilled water to remove unbounded labeled antibodies. On addition of 
substrate (TMB) a color will develop, indicating the presence of ferritin.  
 
 The absorbance is then measured at 450nm. The concentration of 
ferritin is directly proportional to the colour intensity of the test sample. This 
test has been calibrated against NIBSC-WHO – 80/602 human liver standard.  
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SERUM IRON AND TIBC MEASUREMENT  
 It was determined using iron and TBC kit from CREST biosystems 
(Ferrozine method). 
 
PRINCIPLE  
 Iron, bound to transferring is released in acidic medium and ferric irons 
are reduced to ferrous irons. Fe++ reacts with ferrozine to form a violet colored 
complex.  
 
 The intensity of the complex formed is directly proportional to the 
amount of iron present in the sample.  
 
 Fe++ Acidic Medium  Fe++ 
 Fe++ + Ferrozine  violet coloured complex  
 
TIBC  
   The serum is treated with excess ferrous to saturate the iron binding 
sites on transferring. The excess Fe++ is adsorbed and precipitated and the iron 
content in the supernatant is measured to give TIBC. 
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NORMAL VALUES OF PARAMETERS ASSESSED45  
Parameter  Age (years) Male  Female  
Hb g% 10-17 
>18 
12.5-16.1 
13.5-18.0 
12-15.0 
12.5-16.0 
Hct 10-17 
>18 
36-47 
45-52 
35-45 
37-47 
MCV (fl) 10-17 
>18 
78-95 
78-100 
78-95 
78-100 
MCH pg 10-17 
>18 
26-32 
27-31 
26-32 
27-31 
MCHC  32-36 32-36 
Serum Iron µg/dl  65-17.5 50-70 
TIBC µg/dl  200 - 400 200-400 
Sr. Ferritin ng/dl  20-300 15-120 
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REVIEW OF LITERATURE 
 
 Congenital cyanotic heart disease can be considered as a systemic 
disorder that affects haematological, respiratory, renal skeletal and central 
nervous system20,32. Haematological manifestations other than erythrocytosis 
include relative iron deficiency anemia, coagulation disorders and functional 
platelet disorders. 
  
 In the presence of marked right to left shunt since birth, as in cyanotic 
heart diseases there will be no normal postnatal fall of hemoglobin. The blood 
by passes the lungs and hence the oxygenation. The hypoxemic blood on 
reaching the kidney elicits erythropoietin response and plenty of 
erythropoietin is released. Erythropoietin stimulates the bone marrow to 
produce more red blood cells there by increasing the red cell count, 
hemoglobin and hematocrit14,26.     
 
 The increase in red cells may cause increased oxygen carrying capacity 
of the blood. The blood volume is also increased due to increase in red blood 
cells. But at the same time plasma volume may get reduced. This reduces 
blood velocity. The stagnation of blood in the circulation causes tissue 
hypoxia which stimulates more and more erythropoietin and increased amount 
of red blood cells are produced inspite of a very high hematocrit.  
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 Based on iron status of the body, cyanotic patients with erythrocytosis 
can be classified into two categories19. 
 
1. Compensated erythrocytosis in iron sufficient state.  
2. Decompensated erythrocytosis in iron depleted state.  
 
In iron sufficient state, patients with compensated erythrocytosis 
establish equilibrium hematocrit. Since iron is present in sufficient amount, 
haemoglobuin synthesis is enhanced and tissue oxygenation improves. Once a 
particular level of hematocrit is reached, the stimulus for erythropoietin 
secretion is removed and hematocrit will be stable. Symptoms of 
hyperviscocity are mild or absent if hematocrit is less than 65% when 
hematocrit ≥ 70% the symptoms are of moderate severity. Hence phlebotomy 
is rarely required.  
 
Patients with decompensated erythrocytosis fail to achieve equilibrium. 
In this situation, tissue hypoxia stimulates erythropoietin secretion which in 
turn will stimulate the bone marrow to produce increased amount of red blood 
cells. But due to iron deficiency, sufficient amount of hemoglobin will not be 
produced and hence tissue hypoxia will not be eliminated. Hence the stimulus 
for erythropoietin persists and red blood cell production is uncontrolled. This 
further increases the hematocrit. These patients may have moderate to severe 
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symptoms due to hyperviscocity. In this situation, therapeutic phlebotomy is 
required frequently that further causes depletion of iron stores. 
 
Causes of iron deficiency in congenital cyanotic heart disease  
 The following causes can be attributed to the presence of iron 
deficiency in cyanotic patients.  
 
1. Dietary deficiency of iron is one of the most important cause of anemia 
in tropical countries. Appetite and absorption of nutrients are decreased 
in cyanotic patients.  
2. The requirement of iron for proliferating red cells is increased i.e., the 
patient may have normal total body iron which may not be enough to 
cope up with excessive cell proliferation. 
3. Repeated phlebotomies also reduce the iron stores but this is 
uncommon in our population.  
4. Cyanotic heart disease patients have disturbances related to platelets 
and coagualtion cascade. They have decreased Factor, V, VII and 
fibrinogen. Hence, they have bleeding tendencies. Rarely, it may be 
severe enough to cause blood loss anemia.  
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Effects of iron deficiency  
 Iron deficiency decreases oxygen carrying capacity of blood. In patient 
with cyanotic heart disease, iron deficiency will further aggravate tissue 
hypoxia due to right to left shunt.  
 
 Iron deficient state also exacerbates cyanotic spells and metabolic 
acidosis.  
 Iron deficient red blood cells are rigid and resist deformation in 
microcirculation and elevates blood viscosity. This increases the risk of 
cerebrovascular accidents.  
 
 In iron replete state, cerebrovascular accidents are uncommon if 
hematocrit is less than 65%. But in iron deficient state, cerebrovascular 
accidents occur even if hematocrit is less than 65%21. 
 
 According to Joseph K. Perloff symptoms of hyperviscosity occurring 
in patients with hematouril less than 65% are almost always due to iron 
deficiency19. Iron deficiency plays a crucial role in causing complications in 
patient with cyanotic heart disease. Simple iron deficient state without anemia 
is enough to aggravate complications. The correction of iron deficiency 
improves the quality of life in cyanotic patients.  
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 The iron supplementation in iron deficient cyanotic heart disease 
patients must be closely monitored19. The hematocrit increases rapidly on iron 
supplementation. Correction with iron improves exercise tolerance, general 
well being and reduces attacks of cyanotic spells. The symptoms observed at 
low hemoglobin concentration tend to recur if hematocrit rises above 75%. 
Haematocrit measurement based on centrifugation technique causes plasma 
trapping and false elevation of hematocrit values. Hence, hematocrit must be 
measured in automated counters.  
 
 To find out the presence of anemia in a cyanotic patient with 
erythroytosis it is essential to know the sequence of events in deficiency 
before planning to investigate for anemia in a cyanotic heart disease patient. 
Sequence of events following iron deficiency.  
 
 There is an fall in hemosiderin content of liver and bone marrow 
followed by decrease in serum ferritin. Subsequently there is a fall in level of 
serum iron with increase in total iron binding capacity.  
 
 Free erythrocytic porphyrin increases and progressive hypochromia and 
microcystosis ensure. The actual iron containing enzymes are reduced as a last 
event. Variation in red cell size proceeds microcytosis in iron deficiency.  
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 It may be probably due to addition of progressively smaller number of 
red cells in the peripheral blood as iron deficiency worsens.  
 
 Based on these facts iron deficiency can be classified into following 
categories44.       
 
1. Prelatent iron deficiency ‘or’ iron deplete state where there is no 
biochemical evidence of deficiency except a reduction in serum ferritin 
level. Physiologically there is an increased state of iron absorption.  
2.  Latent iron deficiency (or) iron deficiency without anemia. In this 
condition the iron stores are exhausted but the hemoglobin level is 
above the lower limit of normal, plasma iron is decreased and free 
erythrocytic protoporphyrin is elevated.  
3. Early iron deficiency anemia where there is mid to moderate degree of 
anemia with normal red cell indices in some cells.  
4. Late iron deficiency anemia where there is severe anemia with 
associated epithelial changes.  
 
Experimentally induced iron deficiency anemia by phlebotomy causes 
no alteration in red cell indices except few abnormal cells in peripheral smear. 
The red cell distribution width is increased in early stages. Mean corpuscular 
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volume gets decreased (Bessman et al) and iron binding capacity will be 
increased. Finally epithelial changes occur.  
 
This knowledge about the sequence of events of iron deficiency helps 
us to diagnose iron deficiency at an early stage even in cyanotic patient with 
erythrocytosis.  
 
ELECTRONIC CELL COUNTERS  
 Red cell indices measured by red cell counters are reliable, 
reproducible and accurate.  
 
 Perloff et al, in 1989 categorically stated that estimation of hematocril 
in patients with cyanotic congenital heart disease must be based on automated 
blood cell counters.  
 
 Haematocrit measured by cytocentrifugation techniques shows a false 
elevation due to plasma trapping in between rigid iron deficient red blood 
cells.  
 
 Electronic counters measure complete blood count by means of two 
principles.  
1. Electric Impedance 
2. Light scatter  
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In impedance technique, the cells are passed through a small aperture to 
which an electric field has been applied. A small resistance is generated, 
which is measured as pulse height. Cells that do not follow a straight line 
through the field generate a bimodal pulse height. The cellular size is 
proportional to pulse height.  
 
The red cell counters that use impedance technique measure MCV, 
hemoglobin and red blood cell country directly. MCH, hematocrit and MCHC 
are derived values.  
 
The counters that use light scatter technique measure MCHC directly 
and hence MCHC measured by this instrument is more accurate.      
 
RED CELL INDICES  
 Red cell indices are used in classification of anemia.  
Mean corpuscular volume (MCV) 
 It represents the average volume of red cells. It is calculated from red 
cell count and hematocrit. But as previously discussed, in electronic counters 
using electric impedance technology, it is a directly measured index. It is 
expressed in femtoliters (fl). It is decreased in iron deficiency, anemia of 
chronic diseases, lead poisoning, thalaseemia and sideroblastic anemia.  
 
 It is increased in Vit B12 deficiency and folate deficiency.  
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Mean corpuscular Haemoglobin (MCH) 
 It represents the average weight of hemoglobin in each cell. It is 
calculated from hemoglobin and red cell count. It is expressed in picogram 
(Pg).  
 
Mean corpuscular hemoglobin concentration (MCHC) 
  It is calculated from hemoglobin and hematocrit. It is expressed in 
percentage. The electronic counters using light scatter technique directly 
measure MCHC. It is increased in hereditary spherocytosis.  
 
Investigations in a case of iron deficiency anemia in cyanotic heart 
disease  
 Since hemoglobin, hematocrit and red blood counts are elevated in 
cyanotic congenital heart disease we have to rely on other investigations.  
 
 Though there are battery of investigations in the diagnosis of iron 
deficiency anemia, they have their own pit falls.  
 
   During the first two decades of life there is hardly any stainable iron in 
the bone marrow. Hence staining for iron in bone marrow is of limited value 
in first two decades and it is an invasive procedure.  
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 Serum iron is decreased well before other red cell indices to fall below 
the normal value. Serum iron level also decreases in inflammation and 
infection.  
 
 Total iron binding capacity and serum iron are used in calculating 
transferring saturation. A decrease in transferring saturation below 7% is 
diagnostic of iron deficiency. It is also decreased in malnutrition, infection, 
liver disease and nephritic syndrome.    
 
 Free erythrocytic protoporphyrin is a functional index of adequacy of 
iron delivery to the marrow. Porphyrin ring is formed in a developing red 
blood cell before incorporation of iron for heme. When there is iron deficiency 
free erythrocytic protoporphyrin level is increased. An increase of more than 3 
microgram per gram is abnormal.  
 
SERUM FERRITIN  
 Srum ferritin undergoes parallel changes in iron status. Its measurement 
depicts the storage iron pool39,43. It is reduced even if hemoglobin is normal 
and helps in early detection of iron deficiency. In acute and chronic 
inflammation serum iron is shifted to storage sites and hence ferritin is 
increased. Increase inferritin level is seen in many condition. But decrease the 
ferritin level is seen only in iron deficiency anemia.   
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THERAPEUTIC TRIAL  
 It is a well known fact that the determination of hemoglobin response 
to3-4 weeks of iron is the most sensitive and conclusive test for detection of 
subclinical iron deficiency. It was considered as the gold standard in the 
diagnosis of early iron deficiency anemia. A rise of hemoglobin by 1-2g% 
within three to four weeks of iron supplementation is an evidence of early iron 
deficiency. But the response depends upon the patient’s compliance and hence 
there is every chance of bias. Moreover in cyanotic congenital heart disease, 
iron supplementation must be closely monitored. Iron has to be given at a 
lower dosage, as hematocrit will rapidly rise following the correction of 
deficiency. Hence, it is not ideal to try this methods in such a population with 
erythrocytosis. Hence in such cases measurement of red cell indices reveal the 
presence of early iron deficiency anemia.  
 
INCIDENCE OF ANEMIA IN CYANOTIC PATIENTS  
      Taussing found that levels of hemoglobin in the range of 10-13%g 
might constitute anemia in cyanotic heart disease. Similarly Haga et al15, 
postulated that hemoglobin and hematocrit of normal range might constitute 
anemia in patients with cyanotic heart disease and suggested that measurement 
of MCV, MCH and serum ferritin was required to diagnose iron deficiency 
anemia.  
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 Drossons C et al25, studied this red cell indices are serum ferritin of 
cyanotic heart disease patient and found that MCHC was a convenient index 
of iron deficiency anemia.  
 
 Guha et al, studied 33 cases of cyanotic heart disease patients for iron 
deficiency. They correlated red cell indices – mean corpuscular volume, mean 
corpuscular hemoglobin with serum iron and iron binding capacity. They 
concluded that symptoms of hyperviscosity manifested in iron deficiency 
patients at a level of hematocrit lower than that known to produce symptoms. 
They also concluded that low dose iron therapy was effective in relieving 
symptoms of hyperviscosity.  
 
 Nageswara Rao et al (1994)4 studied 32 children with cyanotic heart 
diseases for iron deficiency and concluded red cell indices help in early 
diagnosis of iron deficiency anemia.  
 
CEREBROVASCULAR ACCIDENTS  
         Cerebrovascular accidents are common in cyanotic heart disease 
patients due to erythrocytosis. Tyler and Clark found that cerebrovascular 
accidents occur in 3.8% patients of congenial heart disease and among  them 
14.5% occur in congenital cyanotic heart disease patients.  
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 Phornphutkul et al32 concluded that a majority of cerebrovascular 
accidents occur in less than 2 years of age and about 70% episodes occur in 
less than 4 years of age. They attributed anemia and hypoxia to 
cerebrovascular accidents in less than 2 years of age. The anemia decreases 
the deformability of red blood cells and hence these cells increase the blood 
viscosity in microcirculation at a lower hematocrit thereby leading to vascular 
occlusion. As per their observations 90% of cerebrovascular accident occur in 
patients with transposition of Great arteries and Tetrology of Fallot.  
 
 Linder Kamp et al24, found that hemoglobin concentration more than 
20%g is associated with increased risk of thromboembolic episodes.  
 
 Ammash et al1 in 1996 studied adult patients with cyanotic heart 
disease. They concluded that incidence of cerebrovascular accidents are very 
high in patients with microcytosis with statistical significance (p<0.05). 
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OBSERVATIONS 
 
 35 patients with cyanotic heart disease were studied for the presence of 
anemia. Parameters like hemoglobin, haematocrit, red blood cell count, serum 
ferritin, serum iron and total iron finding capacity were estimated. Mean 
corpuscular volume, mean corpuscular heamglobin and mean corpuscular 
hemoglobin concentration were estimated. These red cell indices were also 
measured for control population of similar age group. The following 
observations were made.  
Table 1 
Age - Sex Distribution 
Cyanotic n = 35 Control n=25 Age in 
years Male Female Male Female 
11-15 6 5 4 4 
16-20 7 4 5 2 
21-25 6 0 3 0 
26-30 2 0 2 1 
31-35 2 0 1 0 
>35 1 2 2 1 
Total  24 11 17 8 
 
It was observed that the Male : Female ratio in the study group and the 
control group was 2.18:1 and 2.12:1 respectively.  
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SEX GROUP CROSS TABULATION 
Table 2 
Group 
Sex 
Study  Control  
Total 
Male  24 17 41 
Female  11 8 19 
Total  35 25 60 
 
X2 0.02 
P=0.96 (not significant) 
Table 3 
Group  Total  Mean age  S.D.  K test  
Study  35 20.77 8.738 T=0.11 
Control  25 20.52 8.352 P = 91 
         (Not significant) 
 
 There was no significant difference in age and sex between study and 
control group. 
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Table 4 
Incidence of Iron depleted state 
 
 Serum Ferritin < 20mg/dl Serum Ferritin >20mg/dl Total % 
Study  26 9 35 74 
Control  11 14 25 14 
    
 X2 = 5.66 % in study group – 74% 
 P = 0.02% in control group – 44%  
 It was observed that the iron depleted state was more common in 
cyanotic patients and it was statistically significant.  
Table 5 
Distribution of Hemoglobin  
 
Hb in gm  Study group  Control group  
<10 0 10 
10-12 2 10 
12-14 10 5 
14-16 17 0 
>16 6 0 
  
 The hemoglobin of the study group varied between 11.5g to 16.8g%, 
while in the control group it was between 8.9g% to 13.5g%. 
 20 patients were anemic in the control population based on hemoglobin 
where as only 5 had hemoglobin in anemic range in the study population.  
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Table 6  
Distribution of Haemotocrit   
Hct% Study group  Control group  
<30 0 10 
30-36 2 10 
36.1-42 10 5 
42.1-48 17 0 
48.1-50 6 0 
 
 The haematocrit varied from 35-50% in study group where as it was 
between 25.5% to 40.5% in the control group.  
 19 patients were anemic in control population based on haemotoric 
where as only 4 had haematocrit in anemic range in study group.  
Table 7  
Distribution of MCV 
MCV (fl) Study group n=35 Control group n=25 
<65 0 2 
65.1-70 3 2 
71.1-75 8 4 
75.1-80 20 4 
81.1-85 3 7 
>85.1 1 5 
 
 The MCV varied between 67.1 fl to 92.0 in study group. It was 
between 64.3 and 97.6 in control group.  
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Table 8  
Red cell parameters in relation to sex 
STUDY GROUP   
 
Male Female 
Parameter 
Mean S.D. Mean S.D. 
Hb g% 14.78 1.35 13.92 1.50 
PCV % 44.43 4.20 41.73 4.56 
MCV fl  76.38 3.84 76.40 6.39 
MCH pg/ cell  25.31 1.17 23.35 2.25 
MCHC g/dl  33.33 0.69 33.35 0.43 
RBC million /cumm 5.86 0.62 5.48 0.76 
Sr. Iron µg/dl 47.96 40.06 42.82 38.98 
TIBC µg/dl 413.33 97.38 394.45 115.63 
Sr. ferritin ng/dl 20.88 17.07 18.55 18.22 
 
 Serum iron was significantly lower and TIBC was significantly 
elevated in females when compared to males.  
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Table 9  
Red cell parameters in relation to sex 
CONTROL GROUP   
 
Male Female 
Parameter 
Mean S.D. Mean S.D. 
Hb g% 10.88 1.49 10.14 1.68 
PCV % 32.63 4.47 30.45 5.00 
MCV fl  80.22 9.62 77.75 6.51 
MCH pg/ cell  26.77 3.20 25.94 2.16 
MCHC g/dl  34.80 0.62 34.30 0.82 
RBC million /cumm 4.07 0.35 4.01 0.59 
Sr. Iron µg/dl 77.94 28.89 54.38 26.52 
TIBC µg/dl 298.82 82.79 365.63 92.00 
Sr. ferritin ng/dl 69.94 46.39 44.63 50.76 
 
  Mean of serum iron serum ferritin significantly lowered and TIBC was 
significantly elevated in females when compared to males.  
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COMPARISON OF RED CELL INDICES IN VARIOUS SUBSETS OF 
PATIENTS AND CONTROLS  
Hemoglobin (g%) 
Table 10-A 
Study  Control  
14.51±1.44 10.64±1.56 
       P = 0.001 
 The hemoglobin was significantly elevated in study group.   
Table 10-B 
CCHD Eisenmenger  
14.55±1.42 14.41±1.56 
       P=0.79 
 There was no significant difference between the both groups.  
Table 10-C 
Iron depleted state  Iron sufficient state 
Study  Control  Study  Control  
14.44±1.54  9.17±0.49 14.72±1.33 11.79±1.02 
P=0.001 P=0.001 
   
 The hemoglobin levels observed between study and control groups in 
both iron depleted and iron sufficient states were statistically significant and it 
was elevated in study group.  
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Table 10-D 
Cyanotic Population  
Iron depleted state  Iron sufficient state  
14.44±1.54 14.72±1.33 
   
 There was no significant difference in hemoglobin values between iron 
depleted and iron sufficient states.  
PACKED CELL VOLUME (%)  
Table 11-A 
Study  Control  
43.58±4.43 31.93±4.66 
       P = 0.001 
 The PCV observed in cyanotic patients was significantly higher than 
normal population.  
Table 11-B 
CCHD Eisenmenger  
43.77±4.35 43.10±1.56 
       P = 0.69 
 
 There was no significant difference among the above groups regarding 
PCV values.  
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Table 11- C 
Iron depleted state  Iron sufficient state 
Study  Control  Study  Control  
43.38±4.46 27.55±1.44 44.13±3.50 35.38±3.06 
P=0.001 P=0.001 
 
PCV, irrespective of the iron status was significantly elevated in the 
cyanotic population.  
Table 11- D 
Cyanotic population 
Iron depleted state  Iron sufficient state  
43.38±4.76 44.13±3.50 
 
 PCV showed no significant different in the above group.  
Mean Corpuscular Volume (fl) 
Table 12-A 
Study  Control  
76.38±4.69 79.43±8.69 
        
P = 0.09 
 There was no statistical difference in MCV among the cyanotic and 
control population.  
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Table 12-B 
CCHD Eisenmenger  
75.63±4.26 78.27±5.11 
       P=0.014 
 MCV showed no significant difference among the above group.  
Table 12-C 
Iron depleted state  Iron sufficient state 
Study  Control  Study  Control  
76.00±4.86 73.78±6.24 77.47±4.23 83.86±7.82 
P=0.25 P=0.04 
   
 MCV was significantly reduced in cyanotic population of iron 
sufficient group but no significant difference was noted in iron depleted state. .  
Table 12-D 
Cyanotic Population  
Iron depleted state  Iron sufficient state  
76.00±4.86 77.47±4.23 
   
 No significant difference was observed between the above groups.  
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MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION  
Table 13-A 
Cyanotic  Control  
33.37±0.62 34.36±0.62 
       P = 0.57 
 There was no significant difference observed in MCHC of both groups.  
Table 13-B 
CCHD Eisenmenger  
33.26±0.48 33.64±0.84 
       P = 0.10 
 
 There was insignificant difference in the value of MCHC in above 
groups.  
Table 13- C 
Iron depleted state  Iron sufficient state 
Study  Control  Study  Control  
33.37±0.69 34.80±0.62 33.37±0.36 33.80±0.62 
P=0.73 P=0.49 
 
No difference was observed in iron deplete andiron sufficient group.   
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Table 11- D 
Cyanotic population 
Iron depleted state  Iron sufficient state  
33.37±0.69 33.37±0.36 
 
 No statistical difference was noted in MCHC in above group. 
RBC COUNT  
Table 14-A 
Cyanotic  Control  
5.74±0.68 4.04±0.43 
       P = 0.001 
RBC count was significantly elevated in cyanotic patients.  
Table 14-B 
CCHD Eisenmenger  
5.84±0.63 5.51±0.76 
 
 No significant difference was observed in RBC count between CCHD 
and Eisenmenger.   
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Table 14- C 
Iron depleted state  Iron sufficient state 
Study  Control  Study  Control  
5.73±0.68 3.83±0.49 5.80±0.71 4.23±0.33 
P=0.001 P=0.001 
 
The RBC count was significantly decreased in cyanotic population of 
both iron depleted and iron sufficient state.    
Table 11- D 
Cyanotic population 
Iron depleted state  Iron sufficient state  
5.73±0.66 5.80±0.71 
 
 There was no significant difference observed in RBC count among iron 
sufficient and iron depiction cyanotic patients.  
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MEAN CORPUSCULAR HEMOGLOBIN  
Table 15-A 
Study  Control  
25.33±1.55 26.50±2.89 
       P = 0.05 
 There was no statistical difference in MCH in cyanotic and control 
population.  
Table 15-B 
CCHD Eisenmenger  
24.95±1.26 25.27±1.88 
       P = 0.09 
 
 There was no difference in MCH values between the above group.  
 
Table 15- C 
Iron depleted state  Iron sufficient state 
Study  Control  Study  Control  
25.24±1.68 24.6±2.10 5.58±1.54 28±2.58 
P=0.033 P=0.02 
 
In iron sufficient group, there was no significant reduction in MCH in 
cyanotic population. 
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Table 15- D 
Cyanotic population 
Iron depleted state  Iron sufficient state  
25.24±1.68 25.58±1.54 
 
 There was no significant difference in MCH in the above group.  
SERUM IRON  
Table 16-A 
Study  Control  
46.34±39.64 70.40±29.79 
       P = 0.01 
 The serum iron was elevated in control population which was 
statistically significant.  
Table 16-B 
CCHD Eisenmenger  
49.68±41.01 39.50±37.12 
       P = 0.53 
 
 There was no significant difference observed in above two groups.  
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Table 16- C 
Iron depleted state  Iron sufficient state 
Study  Control  Study  Control  
29.96±8.70 40.0±6.33 102.33±41.14 94.29±14.53 
P=0.001 P=0.51 
 
Serum iron was significantly lowered in cyanotic population of iron 
depleted state. This difference was not significant in iron sufficient state.  
Table 16- D 
Cyanotic population 
Iron depleted state  Iron sufficient state  
29.96±8.70 102.33±41.14 
 
 Serum iron was significantly reduced in anemic population of cyanotic 
group.  
TIBC 
Table 17-A 
Study  Control  
407.40±102.11 320.20±89.75 
       P = 0.001 
 There was a significant increase in iron binding capacity in cyanotic 
patients.  
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Table 17-B 
CCHD Eisenmenger  
493.16±103.49 418.0±103.18 
        P = 0.70 
 
 The TIBC in both groups were increased but this showed no statistical 
significant.  
Table 17- C 
Iron depleted state  Iron sufficient state 
Study  Control  Study  Control  
451.92±65.16 399.55±59.46 278.78±77.36 256.86±51.36 
P=0.03 P=0.44 
 
The TIBC value was significantly elevated in cyanotic patients of iron 
depleted population. Though this value was elevated in iron sufficient patients 
with cyanotic the amount of elevation was significant.  
Table 17- D 
Cyanotic population 
Iron depleted state  Iron sufficient state  
451.92±65.16 278.78±77.36 
 
 TIBC was significantly elevated in iron-depleted state of cyanotic 
population. 
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SERUM FERRITIN  
Table 18-A 
Study  Control  
20.77±17.17 61.84±48.29 
         
P = 0.001 
 Serum ferritin was significantly lowered in cyanotic patients.  
Table 18-B 
CCHD Eisenmenger  
20.56±16.41 21.30±19.88 
         
P = 0.91 
 
 There was no significant difference in ferritin levels among the above 
groups.  
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PARAMETERS IN PATIENTS WITH CONGESTIVE CARDIAC 
FAILURE  
Table 19 
Parameter  Mean  SD 
Hb g% 12.9 0.8 
PCV % 41.3 3.2 
MCV fl  68.9 1.5 
Sr. Ferritin ng/dl 8.25 1.10 
 
         n=3 
 The incidence of congestive cardiac failure was 8% in our study. The 
mean ferritin and MCV was significantly reduced in patients with congestive 
cardiac failure when compared to others in cyanotic group.   
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DISCUSSION 
 
 The observations made in respect of hemoglobin (Hb), hematocrit (Hct) 
Red Blood Cell (RBC count), Mean Corpuscular Volume (MCV), Mean 
Corpuscular Hemoglobin (MCH), Mean Corpuscular Hemologbin 
Concentration (MCHC), serum iron, serum ferritin, Total Iron Binding 
Capacity (TIBC) were analysed and following inferences were drawn.  
 
AGE DISTRIBUTION  
 Study population comprised of 22 patients in the age group of 11-20 
years, 10 between 20-30 years of age and 5 were above 30 years. The control 
population comprised of 15 in age group between 11-20 years, 6 between 20-
30 years of age and 4 were above 30 years. The control group matched with 
the study group in respect to age distribution.  
 
SEX DISTRIBUTION  
   There were 24 males and 11 females in the study group. The control 
group comprised of 17 males and 8 females. The male : female ratio in study 
group was 2.18:1 and in control group was 2.12:1. The control group matched 
with the study group in respect to sex.  
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DISTRIBUTION OF HEART DISEASES IN STUDY POPULATION  
 14 patients had tetrology of fallot, 10 were suffering from Eisenmenger 
syndrome 3 had double outlet right ventricle, 2 had total anomalous 
pulmonary venous communication, 2 had transposition of great arteries. We 
had one each with truncus arteriosus, Ebstein’s anomaly, pulmonary AV 
malformation and tricuspid atresia.  
 
HAEMOGLOBIN  
  The hemoglobin in the cyanotic group varied between 11.5g% to 
16.8g%. In the control group it was between 8.9g% to 13.g%. Only five 
patients were considered anemic when hemoglobin alone was taken as a out 
off point in the study group. 20 patients were anemic in the control group.  
 
 The mean hemoglobin of study population was 14.51± 1.44g%. It was 
10.04±1.56g% in the control population. The hemoglobin was significantly 
elevated in the study group. Though the hemoglobin values were lower in 
females than in males in the cyanotic population, this was not significant. As 
discussed previously, the chronic cyanotic state stimulates erythropoietin 
production from kidneys and bone marrow is stimulated thereby the 
hemoglobin levels in cyanotic population is elevated. Hence hemoglobin was 
not considered as a sensitive marker of anemia in cyanotic patients. 
       
 43
The hemoglobin level of our patients correlated well with that observed 
by others.  
Table 20-A  
Study Population   
Parameter  Present study  Nagaswara Rao et al  
Hb  14.51±1.44 14.25±1.32 
  
Table 20-B 
Iron depleted state Iron sufficient steate 
Parameter 
Present study 
Nagaswara Rao 
et al 
Present 
study 
Nagaswara 
Rao et al 
Hb  14.44±1.54 15.77±3.17 14.72±1.33 14.04±2.05 
 
 There was no significant differences in the levels of hemoglobin among 
iron depleted state and iron sufficient population of cyanotic patients.   
 
PACKED CELL VOLUME (HEMETOCRIT) 
 The mean hemetocrit varied from 35-50% in the cyanotic group where 
as it was between 25.5-40.5% in the control group.  
 The mean hemetocrit was 43.58±4.42 in the cyanotic patients with was 
significantly higher than that observed in control population. Only four 
patients fell into anemic group in cyanotic population based on hematocrit 
alone. It was safely inferred that hematocrit is not a sensitive marker of 
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anemia in cyanotic patients. The elevated values in cyanotic patients was 
attributed to chronic hypoxemic state. 
Table 21 
Cyanotic Patient 
Parameter  Present study  Nagaswara Rao et al  
Hct  43.58±4.43 46.75±3.85 
 
 The values observed in our study were similar to that observed by 
others.    
 
RED BLOOD CELL COUNT  
 The mean RBC count in the study group was 5.74±0.68 × 1012 and this 
was significantly elevated that that of the control group. This may be 
attributed to the increased erythropoietin level that stimulates bone marrow to 
produce more RBCs. Our study correlated well with those conducted by 
others.  
Table 22 
Parameter  Present study  Nagaswara Rao et al  
RBC count   5.74±0.68 6.06±1.53 
 
 None in the study group was considered anemic based on RBC count. 
Hence RBC count was considered as an insensitive marker of anemia in 
cyanotic heart disease.  
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MEAN CORPUSCULAR VOLUME  
 The MCV varied between 67.1 fl to 92.0 fl in the study group. It was 
between 64.3 fl and 97.0 fl in the control group.  
 
 The mean corpuscular volume in cyanotic population was 76.38±4.66 
fl. The MCV was decreased in cyanotic population but this decrease in 
absolute value was insignificant. Since there was no statistical significance, 
the cutoff value of MCV to define anemia will be similar to that of normal 
population.  
 
 21 of our cyanotic patients was considered anemic based MCV value 
alone. Since 26 of our patients were in iron depleted state and MCV detected 
most of them, it can be considered as a sensitive marker of anemia.  
 
 This observation is in line with that observed by Sami Ulus et al who 
observed that 23 of his patients with decreased MCV values among 28 of iron 
depleted cyanotic patients.  
Table 23 
 Present study  Sami Ulus et al  
Patient with decreased MCV 21 23 
        
 The mean corpuscular hemoglobin in the cyanotic group was 
25.33±1.55 and in the control population it was 26.50±2.89. This reduction 
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was statistically significant. 20 of the cyanotic patients were anemic based on 
MCH values. Though MCH correlated well with MCV, the latter was more 
reliable indicator of anemia since MCH was a derived value.  
 
 Sami Ulus et al and Haga P et al (1993) observed that both MCV, 
MCH revealed iron deficiency in cyanotic heart disease which were in line 
with our study.  
 
MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION 
(MCHC) 
 The mean of MCHC of cyanotic group was 33.37±0.62 and the mean 
of control group was 34.46±0.62. There was no statistical significant between 
the means of MCHC in both group.  
 
 This was similar to that observed by Nagaswara Rao et al.  
Table 24 
Present study  Nagaswara Rao et al  
33.37±0.62 31.99±1.55 
   
 All of our patients had MCHC within normal limits.  
 
 MCHC depends on hemoglobin and hemotocrit. In iron deficiency 
anemia both hemoglobin and hemetocrit are reduced and hence the ratio 
remains unchanged. This explains the normal values observed in our patients.  
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 Moreover in electronic cell countries, using electric impedance 
technology, MCHC will be a derived value and hence less reliable.  
 
 In our study, MCHC was lower in cyanotic population. Denis Miller 
observed that hematocrit need not fall in parallel to hemoglobin in all cases. 
Resove and Joseph K. Perloff studied the hematological parameters of 40 
adults with cyanotic congenital heart disease and reported that a subset of 
patients had an unstable hemetocrit that rose frequently. Those patients with 
unstable hematocrit were iron deficient when compared to others. The authors 
came to a conclusion that iron deficiency in cyanotic patients caused an 
adaptive failure and these patients show an excessive erythroid response. 
Hence their hematocrit will be elevated unlike the usual fall in iron deficiency. 
Since hematocrit forms the denominator in the calculation of MCHC, any 
increase in hematocrit reduces MCHC. This explains the lower levels of 
MCHC observed in our patients.  
 David Bessman and Edward Custner studied the hematological values 
in 13 polycythemic patients. They observed that MCHC fell by only 0.5% 
whereas other hematological indices showed a dramatic fall well ahead of 
MCHC. Hence MCHC from our study was not a sensitive indicator to 
diagnose anemia in cyanotic patient.  
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SERUM IRON  
 The mean serum iron in the cyanotic population was 46.34±39.64. The 
control population had their mean as 70.40±29.79. The serum iron was 
reduced significantly in cyanotic population. 24 of our 35 patients had iron 
levels lower than the normal values. Drosses et al., studied 38 patients of 
cyanotic heart diseases. 37.5% of his cyanotic population had low level of 
serum iron.  
Table 25 
 Present study  
n=35  
Drosses et al  
n=38  
% of population with low 
serum iron  
66% 37.5% 
   
 In our study 66% of cyanotic population had low level of serum iron.  
 
 This difference can be attributed to the high prevalence of nutritional 
deficiency anemia (especially Fe) and chronic hook worm infestation in our 
population.  
 
TOTAL IRON BINDING CAPACITY  
 TIBC was estimated in both cyanotic and control group. The means of 
TIBC in cyanotic and control group were 407.40±102.11 and 320.20±89.75 
respectively. The total iron binding capacity in the cyanotic population was 
markedly elevated. This difference was statistically significant 24 patients in 
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cyanotic population had elevated values and this correlated well with the 
serum iron values. TIBC had an inverse relationship with that of serum iron 
values.  
SERUM FERRITIN  
     Serum ferritin, the storage form of iron, was estimated in our control 
and cyanotic population. The mean in cyanotic population was 20.77±17.17 
and the mean of serum ferritin in control population was 61.84±48.29. The 
cyanotic population had reduced levels of serum ferritin. This reduction was 
statistically significant. 26 of our cyanotic patients had low serum ferritin 
levels, that accounted for 74% of our cyanotic population. In the control 
population 44% had reduced serum ferritin levels.   
Table 26 
 Iron depleted 
state  
Iron sufficient 
population  
% of iron depleted 
population 
Cyanotic   26 9 74% 
Control  11 14 44% 
     
         P=0.02 
 
 This iron depleted state was found to be more common in cyanotic 
population and this was statistically significant. 
 The increased incidence of iron depleted state in cyanotic population 
can be attributed to the  
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i) Increased prevalence of iron deficiency anemia in general 
population.  
ii) Chronic hypoxia in cyanotic state causes an augmented 
erythropoietin response which inturn leads to increase utilisation of 
iron by the expanded bone marrow.  
iii) Bleeding disorders seen in cyanotic heart diseases patient.  
 
Serum ferritin was found to be increased in conditions like acute 
infectious, inflammation iron overload state. But decreased ferritin was noted 
only in iron deficiency state. In our study ferritin emerged to be a sensitive 
indicator of iron deficiency which was also observed by Haga et al.  
Table 27 
Comparison of iron deplete state with other studies 
Group  Iron depleted state  
Sami Ulas et al n=44 62.6 
Gaiha et al n=33 18.2 
Present study n=25 74 
 
 This variation in iron depleted state can be attributed to the varying 
prevalence of iron deficiency anemia in general population.  
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Comparison of parameters between congenital cyanotic heart disease and 
Eisenmenger syndrome  
 We had 10 patients with Eisenmenger syndrome and 25 patients with 
congenital cyanotic heart disease. The hematological parameters and the iron 
stores were compared between the congenital cyanotic heart disease and the 
Eisenmenger syndrome. It was inferred that there was no significant 
difference in the red cell of parameters and iron stores. The nature of cardiac 
disease had no effect on the anemic states. The cyanotic state which was 
common manifestation of the above two conditions that determined the 
severity of anemia.  
 
Comparison of variables among iron depleted and iron sufficient patients 
   Serum iron was significantly lower and TIBC was significantly higher 
in iron depleted cyanotic population when compared to iron sufficient 
cyanotic population.  
 
 The means of other red cell indices were not statistically significant.  
 
Comparison of variables between cyanotic and control group  
 Hb, PCV, RBC count were significantly elevated in the cyanotic 
population which can be explained by increased erythroid response to chronic 
hypoxemia in this subgroup.  
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 Serum iron and serum ferritin were significantly lowered in cyanotic 
population.  
 
SEX DIFFERENCE IN RED CELL INDICES  
 Neither cyanotic nor the control population showed any significant 
difference in red cell induces among the both sexes.  
 
 Female cyanotic patients significantly differed from males only in 
serum iron and TIBC. 
Table29 – Cyanotic  
Parameter  Female  Male  
Serum iron  42.82±38.98 47.96±40.66 
TIBC 349.45±115.63 413.33±97.38 
      
 Similar trend was observed in control population as well.  
 
Table 30 – Control 
Parameter  Female  Male  
Serum iron  54.38±26.52 77.94±28.29 
TIBC 365.63±92.10 298.82±82.79 
Serum ferritin  44.63±50.76 69.94±46.39 
 
 This could be explained by the increased prevalence of iron deficiency 
state in female population.  
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CONGESTIVE CARDIAC FAILURE  
 We had 3 patients with congestive cardiac failure. The incidence was 
8%. Two were diagnosed to have TOF and one had TGA. All had low MCV 
and very low serum feritin levels.  
Parameter  CCF Cyanotic patients  
Hb g% 12.9±0.8 14.78±1.35 
PCV 41.3±3.2 44.43±4.20 
MCV fl  68.3±1.5 76.38±3.84 
Srum Ferritin ng/dl 8.25±1.10 20.88±17.02 
 
 The parameters were significantly decreased in cyanotic patients with 
congestive cardiac failure. This fact can be explained that severe anemia 
aggravates failure. Since we had only 3 patients, this requires a larger study to 
confirm the report.  
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CONCLUSION AND SUMMARY 
 
• 35 patients were analysed for iron deficiency anemia in congenital 
cyanotic heart disease.  
• Serum ferritin was observed to be the ideal indicator to diagnose iron 
deplete state at an early state. When used along with MCV iron 
deficiency anemia can be diagnosed in cyanotic patient.  
• The incidence of iron depleted state was 74% in cyanotic population.  
• The incidence of iron deficiency anemia in our study was 60%. 
• Incidence of congestive cardiac failure was high in patients with serum 
ferritin level <10ng/dl. 
• Hemoglobin, hematocrit, MCHC were not useful in diagnosing iron 
deficiency anemia in cyanotic heart disease patients.  
• There was no difference in the red cell parameters and iron status 
between Eisenmenger syndrome and cyanotic heart disease.  
• No significant different was observed among red cell parameters 
between male and female cyanotic heart disease patients.   
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PROFORMA 
A study on iron deficiency anemia in children with cyanotic congenital 
heart disease  
Name  
Age  
Sex  
Provisional Diagnosis  
Final Diagnosis  
Cyanosis  
Clubbing – Gr I/II/III/IV 
H/o Iron intake present / absent  
If present – duration  
Signs of anemia –present / absent  
Neurological complication – if any  
Investigations  
Hb 
Hct 
RBC 
MCV 
MCHC 
Sr. Ferritin  
Sr. Iron  
TIBC 
S.No. Age Sex Diagnosis Hb PCV MCV MCH MCHC RBC Sr. Iron TIBC Sr.Ferritin
1 21 M TA 16.5 50 72.9 24 33 6.87 35 450 26
2 13 M TAPVC 15.8 47 75.3 25.3 33.6 6.24 20 420 10
3 20 M ToF 14.5 44 78.8 24.3 32.2 5.96 40 430 20
4 15 M ToF 13.8 41 70 23.6 33.6 5.85 3 475 10
5 16 M ToF 15.3 46 75.2 25 33.2 6.12 35 435 12
6 20 M ToF 16.2 49 76 25.1 33 6.45 33 510 12
7 23 M ToF 16.8 50 79.1 26.6 33.6 6.32 20 440 8
8 22 M ToF 15.5 47 75.1 24.8 32.9 6.26 18 535 10
9 15 M ToF 14.2 43 83.9 27.7 33 5.12 120 310 44
10 25 M ToF 15 45 76.8 25.6 33.3 5.86 40 435 12
11 24 M TAPVC 16.2 49 75.6 25 33.1 6.48 18 490 8
12 29 M Ebstein 12.2 36.6 84.9 26.8 33.9 4.24 95 235 65
13 16 M dorv, ps, vsd 13.8 41 70.2 23.6 33.7 5.84 38 410 15
14 12 M dorv, ps, vsd 14.8 44 76.9 25.9 33.6 5.72 145 230 42
15 18 M Tof, PA 13.5 41 69.7 23 32.9 5.88 28 455 12
16 13 M ta, VSD 15.2 47 78.1 25.2 32.3 6.02 16 525 8
17 21 M PAVM 14.8 44 75.2 25.3 33.6 5.85 48 350 22
18 19 M vsdreversal 11.5 34 73.4 26.4 35.9 4.36 22 480 15
MASTER CHART 
19 31 M vsdreversal 16.2 49 78 25.8 33 6.28 18 465 10
20 29 M vsdreversal 14.8 44 736 24.2 33.6 5.98 132 230 64
21 33 M asdreversal 12.6 38 76.3 25.3 33.2 4.98 35 390 16
22 49 M asdreversal 15.6 47 80 26.4 33.2 5.92 19 515 8
23 13 M ecdreversal 14.8 44 80.7 27.1 33.6 5.45 26 470 14
24 18 M ToF 15.2 45.6 77.3 25.5 33 5.45 120 235 38
25 12 F Itga,ps,vsd 12.8 38 78.8 26.6 33.6 4.82 20 465 10
26 20 F dorv, ps, vsd 16.2 49 72.3 24.1 33 6.72 30 470 8
27 17 F ToF 14.8 44 75.2 25.3 33.6 5.85 148 234 60
28 13 F ToF 11.8 35 70.1 23.8 33.7 4.96 20 515 8
29 17 F ToF 13.5 41 79.8 24.3 32.9 5.14 45 350 18
30 13 F ToF 12.2 37 76.4 25.2 34.3 4.84 25 465 16
31 13 F Ctga,ps,vsd 13.2 40 67.1 22.1 33 5.96 40 210 20
32 14 F pdareversal 14.8 44 74.6 25.1 33.6 5.9 25 435 18
33 39 F asdreversal 15.8 47 76.8 25.8 33.6 6.12 20 475 8
34 38 F asdreversal 12.8 38 92 31.1 33.7 4.12 20 485 8
35 16 F vsdreversal 15.2 46 77.3 25.5 33 5.95 78 235 52
SEX DISTRIBUTION
69%
31%
Male Female 
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